Georgios Trichas
Board Member
Pharmaceutical Sciences
Acesion Pharma Ltd
Denmark
Biography
Georgios (George) Trichas is a Board Member of Acesion Pharma representing the Wellcome Trust. George is a Partner in Innovations and joined Wellcome in 2012. He is a member of the internal decision-making group for the allocation of the £100m annual Innovations budget. George is also the former head of the £2m Innovations annual seed fund (Pathfinders Awards) and the former head of the £30m Innovative Engineering for Health initiative. He manages a diverse investment portfolio of preclinical and clinical projects in therapeutics and vaccines and led Wellcome's investment in Glycovaxyn which was acquired by GSK for $190m. Prior to joining Wellcome, George worked as Business Development Manager at QM Innovation, the technology transfer office of Queen Mary University of London. George gained his DPhil in Human Anatomy and Genetics from the University of Oxford where he also worked as a postdoc. In addition to his DPhil, George also holds an MSc in Molecular Basis of Human Diseases from the University of Crete.
Research Interest
Pharmaceutical Sciences
